University of Cologne | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug information and related clinical trials

Explore a comprehensive list of organizations, including their profiles and details.

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

DeepMed Research

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

HD10 for Early Stages

Phase 3

Completed

Conditions: Hodgkin´s Lymphoma

Interventions: Drug: Adriamycin
Drug: Bleomycin
Drug: Vinblastine
Drug: DTIC
Radiation: 20 Gy IF-RT
Radiation: 30 Gy IF-RT

First Posted Date: 2005-12-13

Last Posted Date: 2011-07-29

Lead Sponsor: University of Cologne

Target Recruit Count: 1370

Registration Number: NCT00265018

Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

Phase 3

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: Fludarabine

First Posted Date: 2005-12-07

Last Posted Date: 2020-02-20

Lead Sponsor: German CLL Study Group

Target Recruit Count: 877

Registration Number: NCT00262782

Locations: 🇩🇪
Internistische Praxis - Neuenkirchen, Neuenkirchen, Germany
🇩🇪
Klinikum St. Marien, Amberg, Germany
🇩🇪
Internistische Praxis - Arnstadt, Arnstadt, Germany

and more 112 locations

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase 3

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: Chlorambucil
Drug: Fludarabine

First Posted Date: 2005-12-07

Last Posted Date: 2019-05-23

Lead Sponsor: German CLL Study Group

Target Recruit Count: 206

Registration Number: NCT00262795

Locations: 🇩🇪
Onkologische Schwerpunktpraxis, Cottbus, Germany
🇦🇹
Hanuschkrankenhaus, Vienna, Austria
🇩🇪
Saint Josef - Hospital Bochum, Bochum, Germany

and more 85 locations

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Phase 3

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Velcade (Bortezomib)
Drug: Thalidomide
Drug: Dexamethasone

First Posted Date: 2005-11-22

Last Posted Date: 2021-10-18

Lead Sponsor: European Society for Blood and Marrow Transplantation

Target Recruit Count: 269

Registration Number: NCT00256776

Locations: 🇧🇪
Saint Joseph, Gilly, Belgium
🇨🇭
Stadtdpital Triemli, Zurich, Switzerland
🇦🇹
Medizinische Universitaet Wien, Vienna, Austria

and more 70 locations

Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants

Phase 3

Completed

Conditions: Nephrocalcinosis

First Posted Date: 2005-11-07

Last Posted Date: 2012-07-03

Lead Sponsor: University of Cologne

Target Recruit Count: 80

Registration Number: NCT00249951

Locations: 🇩🇪
Prof. Dr. Bernd Hoppe, Cologne, Germany

Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis

Phase 4

Completed

Conditions: Psychoses
Schizophrenia

Interventions: Behavioral: Supportive management
Drug: Amisulpride

First Posted Date: 2005-09-20

Last Posted Date: 2014-12-24

Lead Sponsor: University of Cologne

Target Recruit Count: 124

Registration Number: NCT00204061

Locations: 🇩🇪
Department of Psychiatry and Psycotherapy University of Cologne, Cologne, North Rhine-Westphalia, Germany

Psychological Intervention for Persons in the Early Initial Prodromal State

Phase 3

Conditions: Psychosis
Schizophrenia

First Posted Date: 2005-09-20

Last Posted Date: 2006-01-12

Lead Sponsor: University of Cologne

Target Recruit Count: 126

Registration Number: NCT00204087

Locations: 🇩🇪
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, North Rhine-Westphalia, Germany

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Phase 2

Completed

Conditions: Hyperlipidemia
HIV Infections

First Posted Date: 2005-09-16

Last Posted Date: 2020-11-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 30

Registration Number: NCT00184951

Locations: 🇳🇱
University of Leiden, Leiden, Netherlands
🇳🇱
University of Amsterdam, Amsterdam, Netherlands
🇩🇪
University of Bonn, Bonn, Germany

and more 2 locations

Psychological Intervention for Relapse Prevention in First Episode Schizophrenia

Not Applicable

Conditions: Schizophrenic Disorders

First Posted Date: 2005-09-12

Last Posted Date: 2005-09-12

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 106

Registration Number: NCT00161408

Locations: 🇩🇪
Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
🇩🇪
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
🇩🇪
Department of Psychiatry and Psychotherapy, University of Duesseldorf, Duesseldorf, Germany

and more 2 locations

Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

Phase 3

Terminated

Conditions: Leukemia, Myelocytic, Acute

First Posted Date: 2005-09-09

Last Posted Date: 2006-11-14

Lead Sponsor: University of Cologne

Target Recruit Count: 150

Registration Number: NCT00152594

Locations: 🇩🇪
Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
🇩🇪
Universitätsklinikum Mannheim, Universität Heidelberg, Heidelberg, Germany
🇩🇪
Klinikum der Universität Köln, Köln, Germany

Prev
1
37
38
39
40
41
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy